Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trine Bertelsen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Ugeskrift for Laeger|September 10, 2013
[Children with infantile haemangiomas should be worked-up for PHACE syndrome]Trine Bertelsen, Maria Luise Salskov-Iversen, Birgitte Stausbøl-Grøn, et al.
Experimental Dermatology|February 27, 2026
Dermal Fibroblasts, Not Keratinocytes, Dominate IL-17A/TNF-Driven InflammationLejla Svraka, Hakim Ben Abdallah, Trine Bertelsen, et al.
Case Reports in Dermatology|October 9, 2025
Early Real-Life Experience with Spesolimab in the Treatment of Generalized Pustular Psoriasis: A Case Series of Three Patients Treated in a Compassionate Use ProgramAnne Hald Rittig, Trine Bertelsen, Sascha Dinsen Wreschner Stave, et al.
Ugeskrift for Laeger|November 22, 2024
Anne Hald Rittig, Trine Bertelsen, Carsten Hjorthøj, et al.
Ugeskrift for Laeger|April 2, 2025
[Acne]Clara Emilie Syrene Østergaard, Trine Bertelsen, Hans Lomholt, et al.
JAMA Dermatology|October 22, 2025
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or UstekinumabChristopher Willy Schwarz, Mads Kirchheiner Rasmussen, Trine Bertelsen, et al.
The Journal of Allergy and Clinical Immunology|October 18, 2019
IκBζ is a key player in the antipsoriatic effects of secukinumabTrine Bertelsen, Christine Ljungberg, Thomas Litman, et al.
Experimental Dermatology|December 21, 2010
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in miceTrine Bertelsen, Lars Iversen, Jette Lindorff Riis, et al.
Frontiers in Immunology|March 2, 2026
Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativaHakim Ben Abdallah, Christine Daugaard, Louise Schøsler, et al.
Plos One|September 29, 2022
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatmentSabine Seeler, Liviu-Ionut Moldovan, Trine Bertelsen, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Ugeskrift for Laeger|September 10, 2013
[Children with infantile haemangiomas should be worked-up for PHACE syndrome]Trine Bertelsen, Maria Luise Salskov-Iversen, Birgitte Stausbøl-Grøn, et al.
Experimental Dermatology|February 27, 2026
Dermal Fibroblasts, Not Keratinocytes, Dominate IL-17A/TNF-Driven InflammationLejla Svraka, Hakim Ben Abdallah, Trine Bertelsen, et al.
Case Reports in Dermatology|October 9, 2025
Early Real-Life Experience with Spesolimab in the Treatment of Generalized Pustular Psoriasis: A Case Series of Three Patients Treated in a Compassionate Use ProgramAnne Hald Rittig, Trine Bertelsen, Sascha Dinsen Wreschner Stave, et al.
Ugeskrift for Laeger|November 22, 2024
Anne Hald Rittig, Trine Bertelsen, Carsten Hjorthøj, et al.
Ugeskrift for Laeger|April 2, 2025
[Acne]Clara Emilie Syrene Østergaard, Trine Bertelsen, Hans Lomholt, et al.
JAMA Dermatology|October 22, 2025
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or UstekinumabChristopher Willy Schwarz, Mads Kirchheiner Rasmussen, Trine Bertelsen, et al.
The Journal of Allergy and Clinical Immunology|October 18, 2019
IκBζ is a key player in the antipsoriatic effects of secukinumabTrine Bertelsen, Christine Ljungberg, Thomas Litman, et al.
Experimental Dermatology|December 21, 2010
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in miceTrine Bertelsen, Lars Iversen, Jette Lindorff Riis, et al.
Frontiers in Immunology|March 2, 2026
Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativaHakim Ben Abdallah, Christine Daugaard, Louise Schøsler, et al.
Plos One|September 29, 2022
Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatmentSabine Seeler, Liviu-Ionut Moldovan, Trine Bertelsen, et al.
Pageof 4